Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Infectious Diseases

• Publication date

  2015-05-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/infdis/jiv313PMID 26014800PMCID PMC4655854
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility.

  2015cited by this paper
• Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.

  2015cited by this paper
• An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera.

  2014cited by this paper
• Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type

  2014cited by this paper
• Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons.

  2014cited by this paper
• Association between antibody titers and protection against influenza virus infection within households.

  2014cited by this paper
• Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses

  2014cited by this paper
• Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.

  2014cited by this paper
• Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons

  2014cited by this paper
• Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required.

  2013cited by this paper
• Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase.

  2013cited by this paper
• Influenza vaccine effectiveness in the community and the household.

  2013cited by this paper
• Correlates of protection to influenza virus, where do we go from here?

  2013cited by this paper
• Influenza viral neuraminidase: the forgotten antigen

  2011cited by this paper
• Serologic assays for influenza surveillance, diagnosis and vaccine evaluation

  2011cited by this paper
• Immunogenicity, Boostability, and Sustainability of the Immune Response after Vaccination against Influenza A Virus (H1N1) 2009 in a Healthy Population

  2011cited by this paper
• Persistence of influenza vaccine‐induced antibodies in lung transplant patients between seasons

  2011cited by this paper
• Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection.

  2011cited by this paper
• Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins

  2010cited by this paper
• A miniaturized assay for influenza neuraminidase‐inhibiting antibodies utilizing reverse genetics‐derived antigens

  2009cited by this paper
• Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses

  2008cited by this paper
• Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?

  2008cited by this paper
• Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines.

  2008cited by this paper
• Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007.

  2007cited by this paper
• Influenza vaccine: the challenge of antigenic drift.

  2007cited by this paper
• Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2006cited by this paper
• Recommended composition of influenza virus vaccines for use in the 2005-2006 influenza season.

  2005cited by this paper
• Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?

  2004cited by this paper
• Immunogenicity and protective efficacy of influenza vaccination.

  2004cited by this paper
• Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2000cited by this paper
• Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies.

  1999cited by this paper
• Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period.

  1997cited by this paper
• Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults.

  1996cited by this paper
• Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time.

  1996cited by this paper
• Prevention and control of influenza. Recommendations of the Immunization Practices Advisory Committee (ACIP)

  1990cited by this paper
• Infection with influenza A H1N1: 1. Production and persistence of antibody

  1986cited by this paper
• Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978.

  1983cited by this paper
• Natural infection with influenza A (H3N2). The development, persistence and effect of antibodies to the surface antigens

  1976cited by this paper
• Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.

  1973cited by this paper
• Effect of neuraminidase antibody on Hong Kong influenza.

  1973cited by this paper
• The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

  1972cited by this paper
• Antibody against influenza A2 virus neuraminidase in human sera

  1969cited by this paper

• Cross-binding antibodies capable of neutralising diverse hantaviruses are produced in response to Puumala virus infection

  2026cites this paper
• The shape of waning vaccinal immunity: Implications for control

  2025influential citation
• Expert consensus on the benefits of neuraminidase in conventional influenza vaccines: a Delphi study

  2025cites this paper
• Effect of Current-Season-Only Versus Continuous Two-Season Influenza Vaccination on Mortality in Older Adults: A Propensity-Score-Matched Retrospective Cohort Study

  2025cites this paper
• Characterizing the Short- and Long-Term Temporal Dynamics of Antibody Responses to Influenza Vaccination

  2025cites this paper
• Vaccination against influenza viruses annually: Renewing or narrowing the protective shield?

  2025cites this paper
• A prospective, comparative cohort analysis of influenza antibody waning in Michigan and Hong Kong during periods of low influenza circulation

  2025cites this paper
• Incidence of Circulating Antibodies Against Hemagglutinin of Influenza Viruses in Epidemic Season 2023/2024 in Poland

  2025cites this paper
• Duration of the serological response and effectiveness of the inactivated influenza vaccine in healthy adults aged 18-65 years: a systematic review and meta-analysis.

  2025cites this paper
• High-resolution antibody dynamics following influenza vaccination reveal predominantly weak responses as well as infrequent but durable immunity across the 2014-2022 seasons.

  2025cites this paper
• Effectiveness of influenza vaccination in preventing confirmed influenza cases and hospitalizations in Northern Spain, 2023/24 season: A population-based test-negative case-control study

  2024cites this paper
• Quantifying the impact of pre-vaccination titre and vaccination history on influenza vaccine immunogenicity.

  2024cites this paper
• Vaccine efficacy induced by 2020-2021 seasonal influenza-derived H3N1 virus-like particles co-expressing M2e5x or N2.

  2024cites this paper
• Immune Response Against Influenza in a Cohort of Repeatedly Vaccinated Adults During the 2017/2018 and 2018/2019 Seasons

  2024cites this paper
• Prospects of universal influenza virus vaccine and the current challenges of new antiviral drugs

  2024cites this paper
• Age-dependent heterogeneity in the antigenic effects of mutations to influenza hemagglutinin.

  2024cites this paper
• Neutralizing antibody responses against contemporary and future influenza A(H3N2) viruses in paradoxical clades elicited by repeated and single vaccinations

  2024cites this paper
• Recent Advances, Approaches and Challenges in the Development of Universal Influenza Vaccines

  2024cites this paper
• Intranasal Epitope‐Polymer Vaccine Lodges Resident Memory T Cells Protecting Against Influenza Virus

  2024cites this paper
• Measuring waning protection from seasonal influenza vaccination during nine influenza seasons, Ontario, Canada, 2010/11 to 2018/19

  2024cites this paper
• Quantifying the impact of pre-vaccination titre and vaccination history on influenza vaccine immunogenicity

  2024cites this paper
• Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2

  2024cites this paper
• A randomized, double-blind, non-inferiority trial comparing the immunogenicity and safety of two seasonal inactivated influenza vaccines in adults.

  2023cites this paper
• Immune interference in effectiveness of influenza and COVID-19 vaccination

  2023influential citation
• Does prior vaccination affect the immune response to seasonal influenza vaccination among older adults? Findings from a prospective cohort study in a Northeastern Province of Thailand

  2023cites this paper
• Broadly Protective Neuraminidase-Based Influenza Vaccines and Monoclonal Antibodies: Target Epitopes and Mechanisms of Action

  2023cites this paper
• Intranasal immunization with an RBD-hemagglutinin fusion protein harnesses preexisting immunity to enhance antigen-specific responses

  2023cites this paper
• One-year Antibody Durability Induced by EuCorVac-19, a Liposome-Displayed COVID-19 RBD Subunit Vaccine, in Healthy Korean Subjects.

  2023cites this paper
• Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Cases and Hospitalizations in Navarre, Spain, 2022–2023

  2023cites this paper
• Intraseasonal waning immunity of seasonal influenza vaccine - A systematic review and meta-analysis.

  2023cites this paper
• Epidemiology of influenza virus reinfection in Guangxi, China: a retrospective analysis of a nine-year influenza surveillance data.

  2022cites this paper
• Biphasic waning of hemagglutination inhibition antibody titers after influenza vaccination in children.

  2022cites this paper
• Chronic obstructive pulmonary disease and influenza vaccination effect in preventing outpatient and inpatient influenza cases

  2022cites this paper
• MAS-1, a novel water-in-oil adjuvant/delivery system, with reduced seasonal influenza vaccine hemagglutinin dose may enhance potency, durability and cross-reactivity of antibody responses in the elderly.

  2022cites this paper
• Antibodies directed towards neuraminidase restrict influenza virus replication in primary human bronchial epithelial cells

  2022cites this paper
• A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery system.

  2022cites this paper
• Mild and asymptomatic influenza B virus infection among unvaccinated pregnant persons: Implication for effectiveness of non-pharmaceutical intervention and vaccination to prevent influenza.

  2022cites this paper
• Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post‐vaccination but persist for at least 6 months

  2022cites this paper
• Arrayed Imaging Reflectometry monitoring of anti-viral antibody production throughout vaccination and breakthrough Covid-19

  2022cites this paper
• Repeated influenza vaccination induces similar immune protection as first‐time vaccination but with differing immune responses

  2022cites this paper
• Consumption of yogurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 augments serum antibody titers against seasonal influenza vaccine in healthy adults

  2022cites this paper
• Sustained within-season vaccine effectiveness against influenza-associated hospitalization in children: Evidence from the New Vaccine Surveillance Network, 2015-2016 through 2019-2020.

  2022cites this paper
• Single dose vaccination among infants and toddlers provides modest protection against influenza illness which wanes after 5 months.

  2022cites this paper
• Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model

  2021cites this paper
• Influenza Neuraminidase Characteristics and Potential as a Vaccine Target

  2021cites this paper
• Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses

  2021cites this paper
• Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults

  2021cites this paper
• Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers

  2021cites this paper
• The Human Antibody Response to the Influenza Virus Neuraminidase Following Infection or Vaccination

  2021cites this paper
• Simple models to include influenza vaccination history when evaluating the effect of influenza vaccination

  2021cites this paper
• Effect of influenza vaccination in patients with asthma

  2021cites this paper
• Genetic Analyses of Common Infections in the Avon Longitudinal Study of Parents and Children Cohort

  2021cites this paper
• Targeting Antigens for Universal Influenza Vaccine Development

  2021cites this paper
• Decline in Seasonal Influenza Vaccine Effectiveness With Vaccination Program Maturation: A Systematic Review and Meta-analysis

  2021cites this paper
• Limited evidence for the role of environmental factors in the unusual peak of influenza in Brisbane during the 2018-2019 Australian summer.

  2021cites this paper
• Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy

  2021cites this paper
• Annual influenza vaccination of patients with cardiovascular diseases and changes in hemagglutinin antibody titers: 3-year follow-up data

  2020cites this paper
• Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019.

  2020cites this paper
• Influenza in temperate and tropical Asia: a review of epidemiology and vaccinology

  2020cites this paper
• Clinical-epidemiological profile of deaths from influenza with a history of timely vaccination, Mexico 2010-2018.

  2020cites this paper
• A Population-Based Propensity Score-Matched Study to Assess the Impact of Repeated Vaccination on Vaccine Effectiveness for Influenza-Associated Hospitalization Among the Elderly

  2020cites this paper
• Host immune response–inspired development of the influenza vaccine

  2020cites this paper
• A Population-Based Propensity Score-Matched Study to Assess the Impact of Repeated Vaccination on Vaccine Effectiveness for In fl uenza-Associated Hospitalization Among the Elderly

  2020cites this paper
• Effect of influenza vaccination in preventing laboratory-confirmed influenza hospitalization in patients with diabetes mellitus.

  2020cites this paper
• Influenza A(H1N1)pdm09 But Not A(H3N2) Virus Infection Induces Durable Seroprotection: Results From the Ha Nam Cohort

  2020cites this paper
• Effects of prior season vaccination on current season vaccine effectiveness in the US Flu VE Network, 2012-13 through 2017-18.

  2020cites this paper
• Characterization of humoral and cellular immune features of gamma-irradiated influenza vaccine

  2020cites this paper
• Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine

  2020cites this paper
• Adjuvanted Influenza Vaccines Elicits Higher Antibody Responses against the A(H3N2) Subtype than Non-Adjuvanted Vaccines

  2020cites this paper
• Adjuvanted Influenza Vaccines Elicits Higher Antibody Responses against the A(H3N2) Subtype than Non-Adjuvanted Vaccines.

  2020cites this paper
• Vaccination history as a confounder of studies of influenza vaccine effectiveness

  2019cites this paper
• Waning of influenza vaccine protection: Exploring the trade-offs of changes in vaccination timing among older adults.

  2019cites this paper
• HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy

  2019cites this paper
• Challenges in estimating influenza vaccine effectiveness

  2019cites this paper
• Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013–2014 Through 2015–2016

  2019cites this paper
• Effects of Sequential Influenza A(H1N1)pdm09 Vaccination on Antibody Waning.

  2019influential citation
• The human antibody response to influenza A virus infection and vaccination

  2019cites this paper
• Remaining effect of influenza vaccines received in prior seasons.

  2019cites this paper
• Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens.

  2019cites this paper
• Perfil clínico-epidemiológico de las defunciones por influenza con antecedente de vacunación oportuna, México 2010-2018.

  2019cites this paper
• Multiple Influenza Virus Infections in 4 Consecutive Epidemiological Seasons: A Retrospective Study in Children and Adolescents

  2019cites this paper
• Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and "Universal" Vaccine Development.

  2019cites this paper
• Reply to authorReply To Author.

  2019cites this paper
• Determining optimal community protection strategies for the influenza vaccine

  2019cites this paper
• Immunodominance hierarchy of influenza subtype-specific neutralizing antibody response as a hurdle to effectiveness of polyvalent vaccine

  2018cites this paper
• Neutralizing Antibody Responses to Homologous and Heterologous H1 and H3 Influenza A Strains After Vaccination With Inactivated Trivalent Influenza Vaccine Vary With Age and Prior-year Vaccination.

  2018cites this paper
• The Effects of Birth Year, Age and Sex on Hemagglutination Inhibition Antibody Responses to Influenza Vaccination

  2018cites this paper
• Effectiveness of influenza vaccination on influenza-associated hospitalisations over time among children in Hong Kong: a test-negative case-control study.

  2018cites this paper
• Dissecting Human Antibody Responses Against Influenza A Viruses And Antigenic Changes That Facilitate Immune Escape

  2018cites this paper
• Characterising antibody kinetics from multiple influenza infection and vaccination events in ferrets

  2018cites this paper
• 32 – Influenza Vaccine—Live

  2018cites this paper
• Antibodies against 1940s era a/H1N1 influenza strains a/Weiss/43 and a/FM/1/47 and heterotypic responses after seasonal vaccination of an elderly Spanish population

  2018cites this paper
• Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population

  2018cites this paper
• The Potential Role of Fc-Receptor Functions in the Development of a Universal Influenza Vaccine

  2018cites this paper
• The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness (VE) to Prevent Influenza-Related Hospitalizations over Four Influenza Seasons in Canada.

  2018cites this paper
• Different Repeat Annual Influenza Vaccinations Improve the Antibody Response to Drifted Influenza Strains

  2017cites this paper
• Coated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity.

  2017cites this paper
• Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 Influenza Season

  2017cites this paper
• Background Document for “Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2017-18 Influenza Season” Introduction

  2017cites this paper
• Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness.

  2017cites this paper